A novel heteroplasmic mitochondrial DNA mutation, A8890G, in a patient with juvenile‑onset metabolic syndrome: A case report

Ye,Wei; Chen,Saihui; Jin,Sheng; Lu,Jianxin

doi:10.3892/mmr.2013.1616

A novel heteroplasmic mitochondrial DNA mutation, A8890G, in a patient with juvenile‑onset metabolic syndrome: A case report

Authors:
- Wei Ye
- Saihui Chen
- Sheng Jin
- Jianxin Lu
View Affiliations

Affiliations: Key Laboratory of Laboratory Medicine, Ministry of Education of China, School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou, Zhejiang 325035, P.R. China
Published online on: August 6, 2013 https://doi.org/10.3892/mmr.2013.1616
Pages: 1060-1066

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Metabolic syndrome (MS) is a complex disorder characterized by a group of metabolic abnormalities. In the present study, the case of an 18‑year‑old male who presented with MS characteristics with central obesity (overweight and a waist circumference of 95 cm) and dyslipidemia (high TG, low HDL levels and low apoA‑I/apoB‑100) was reported. The patient's family has maternally inherited diabetes and a number of the patient's maternal relatives present MS features. For the investigation of the mitochondrial DNA variants in the patient and the patient's family, genomic DNA of all the family members were extracted from peripheral blood using routine methods. Amplification of mitochondrial DNA in 24 overlapping fragments by PCR, direct sequencing and denaturing high‑performance liquid chromatography was utilized for genetic analysis. Sequences were compared to the reference sequence to identify variants. Bioinformatic methods and databases were used to analyze conservation of the variants and to predict the protein secondary structure. With the exception of the patient, five relatives were diagnosed with MS. Moreover, 5 of the 8 family members had been diagnosed with diabetes, hearing loss and mild kidney impairment according to serum biochemical analysis. Further molecular genetic analysis indicated that the MS‑associated variant T16189C was detected in this family. Notably, a heteroplasmic mutation A8890G was detected in the patient in the mitochondrial ATP6 gene, which codes the ATP synthase subunit 6 (ATPase6). A8890G changed the highly conserved ATPase6 Lys122 into Glu122 in the mitochondrial inner membrane. However, this mutation was not detected in other family members. In conclusion, the mutation A8890G may affect the function of ATPase 6 and the production of ATP, thus contributing to juvenile‑onset MS. It was not detected in other family members possibly due to the mitochondrial genetic segregation or production of a new germline mutation in the juvenile‑onset patient.

View Figures

View References

1	Wilson FH, Hariri A, Farhi A, et al: A cluster of metabolic defects caused by mutation in a mitochondrial tRNA. Science. 306:1190–1194. 2004. View Article : Google Scholar : PubMed/NCBI
2	Ervin RB: Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity and body mass index: United States, 2003–2006. Natl Health Stat Report. 5:1–7. 2009.PubMed/NCBI
3	Lim S, Shin H, Song JH, et al: Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutrition Examination Survey for 1998–2007. Diabetes Care. 34:1323–1328. 2011.
4	Gu D, Reynolds K, Wu X, et al: Prevalence of the metabolic syndrome and overweight among adults in China. Lancet. 365:1398–1405. 2005. View Article : Google Scholar : PubMed/NCBI
5	Yi Z, Jing J, Liu X-Y, et al: Prevalence of the metabolic syndrome among rural original adults in NingXia, China. BMC Public Health. 10:1402010. View Article : Google Scholar : PubMed/NCBI
6	Alberti KG, Zimmet P and Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome - a new worldwide definition. Lancet. 366:1059–1062. 2005. View Article : Google Scholar : PubMed/NCBI
7	Janssen I, Katzmarzyk PT and Ross R: Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr. 79:379–384. 2004.PubMed/NCBI
8	Ordovas JM: Nutrigenetics, plasma lipids and cardiovascular risk. J Am Diet Assoc. 106:1074–1081; quiz 1083. 2006. View Article : Google Scholar : PubMed/NCBI
9	Frederiksen L, Brødbaek K, Fenger M, et al: Comment: studies of the Pro12Ala polymorphism of the PPAR-gamma gene in the Danish MONICA cohort: homozygosity of the Ala allele confers a decreased risk of the insulin resistance syndrome. J Clin Endocrinol Metab. 87:3989–3992. 2002.PubMed/NCBI
10	Bennet AM, Prince JA, Fei GZ, et al: Interleukin-6 serum levels and genotypes influence the risk for myocardial infarction. Atherosclerosis. 171:359–367. 2003. View Article : Google Scholar : PubMed/NCBI
11	Murase Y, Yagi K, Katsuda Y, et al: An LMNA variant is associated with dyslipidemia and insulin resistance in the Japanese. Metabolism. 51:1017–1021. 2002. View Article : Google Scholar : PubMed/NCBI
12	Steinle NI, Kazlauskaite R, Imumorin IG, et al: Variation in the lamin A/C gene: associations with metabolic syndrome. Arterioscler Thromb Vasc Biol. 24:1708–1713. 2004. View Article : Google Scholar : PubMed/NCBI
13	Juo SH, Lu MY, Bai RK, et al: A common mitochondrial polymorphism 10398A>G is associated metabolic syndrome in a Chinese population. Mitochondrion. 10:294–299. 2010. View Article : Google Scholar
14	Palmieri VO, De Rasmo D, Signorile A, et al: T16189C mitochondrial DNA variant is associated with metabolic syndrome in Caucasian subjects. Nutrition. 27:773–777. 2011. View Article : Google Scholar : PubMed/NCBI
15	Anderson S, Bankier AT, Barrell BG, et al: Sequence and organization of the human mitochondrial genome. Nature. 290:457–465. 1981. View Article : Google Scholar : PubMed/NCBI
16	Yakes FM and Van Houten B: Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci USA. 94:514–519. 1997. View Article : Google Scholar : PubMed/NCBI
17	Soejima A, Inoue K, Takai D, et al: Mitochondrial DNA is required for regulation of glucose-stimulated insulin secretion in a mouse pancreatic beta cell line, MIN6. J Biol Chem. 271:26194–26199. 1996. View Article : Google Scholar : PubMed/NCBI
18	Nishio Y, Kanazawa A, Nagai Y, et al: Regulation and role of the mitochondrial transcription factor in the diabetic rat heart. Ann NY Acad Sci. 1011:78–85. 2004. View Article : Google Scholar : PubMed/NCBI
19	Nisoli E, Clementi E, Carruba MO, et al: Defective mitochondrial biogenesis: a hallmark of the high cardiovascular risk in the metabolic syndrome? Circ Res. 100:795–806. 2007. View Article : Google Scholar : PubMed/NCBI
20	Rieder MJ, Taylor SL, Tobe VO, et al: Automating the identification of DNA variations using quality-based fluorescence re-sequencing: analysis of the human mitochondrial genome. Nucleic Acids Res. 26:967–973. 1998. View Article : Google Scholar : PubMed/NCBI
21	Zimmet P, Alberti KG, Kaufman F, et al: The metabolic syndrome in children and adolescents. Lancet. 370:1541–1542. 2007.
22	Zimmet P, Alberti KG, Kaufman F, et al: The metabolic syndrome in children and adolescents-an IDF consensus report. Pediatr Diabetes. 8:299–306. 2007. View Article : Google Scholar : PubMed/NCBI
23	Mueller EE, Eder W, Ebner S, et al: The mitochondrial T16189C polymorphism is associated with coronary artery disease in Middle European populations. PLoS One. 6:e164552011. View Article : Google Scholar : PubMed/NCBI
24	van den Ouweland JM, Lemkes HH, Ruitenbeek W, et al: Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet. 1:368–371. 1992.PubMed/NCBI
25	Ohkubo K, Yamano A, Nagashima M, et al: Mitochondrial gene mutations in the tRNA(Leu(UUR)) region and diabetes: prevalence and clinical phenotypes in Japan. Clin Chem. 47:1641–1648. 2001.PubMed/NCBI
26	Maassen JA, ‘T Hart LM, Van Essen E, et al: Mitochondrial diabetes: molecular mechanisms and clinical presentation. Diabetes. 53(Suppl 1): S103–S109. 2004. View Article : Google Scholar : PubMed/NCBI
27	Rossmanith W and Karwan RM: Impairment of tRNA processing by point mutations in mitochondrial tRNA(Leu)(UUR) associated with mitochondrial diseases. FEBS Lett. 433:269–274. 1998. View Article : Google Scholar : PubMed/NCBI
28	Janssen GM, Maassen JA and van Den Ouweland JM: The diabetes-associated 3243 mutation in the mitochondrial tRNA(Leu(UUR) gene causes severe mitochondrial dysfunction without a strong decrease in protein synthesis rate. J Biol Chem. 274:29744–29748. 1999. View Article : Google Scholar
29	Chomyn A, Enriquez JA, Micol V, et al: The mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode syndrome-associated human mitochondrial tRNALeu(UUR) mutation causes aminoacylation deficiency and concomitant reduced association of mRNA with ribosomes. J Biol Chem. 275:19198–19209. 2000. View Article : Google Scholar
30	Yasukawa T, Suzuki T, Ueda T, et al: Modification defect at anticodon wobble nucleotide of mitochondrial tRNAs(Leu)(UUR) with pathogenic mutations of mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes. J Biol Chem. 275:4251–4257. 2000. View Article : Google Scholar
31	Park H, Davidson E and King MP: The pathogenic A3243G mutation in human mitochondrial tRNALeu(UUR) decreases the efficiency of aminoacylation. Biochemistry. 42:958–964. 2003. View Article : Google Scholar : PubMed/NCBI
32	Lee JM: Why young adults hold the key to assessing the obesity epidemic in children. Arch Pediatr Adolesc Med. 162:682–687. 2008. View Article : Google Scholar : PubMed/NCBI
33	Hutcheon ML, Duncan TM, Ngai H, et al: Energy-driven subunit rotation at the interface between subunit a and the c oligomer in the F(O) sector of Escherichia coli ATP synthase. Proc Natl Acad Sci USA. 98:8519–8524. 2001. View Article : Google Scholar : PubMed/NCBI
34	Stock D, Leslie AG and Walker JE: Molecular architecture of the rotary motor in ATP synthase. Science. 286:1700–1705. 1999. View Article : Google Scholar : PubMed/NCBI
35	Baracca A, Sgarbi G, Mattiazzi M, et al: Biochemical phenotypes associated with the mitochondrial ATP6 gene mutations at nt8993. Biochim Biophys Acta. 1767:913–919. 2007. View Article : Google Scholar : PubMed/NCBI
36	Santorelli FM, Tanji K, Shanske S, et al: Heterogeneous clinical presentation of the mtDNA NARP/T8993G mutation. Neurology. 49:270–273. 1997. View Article : Google Scholar : PubMed/NCBI
37	Takahashi S, Makita Y, Oki J, et al: De novo mtDNA nt 8993 (T→G) mutation resulting in Leigh syndrome. Am J Hum Genet. 62:717–719. 1998.PubMed/NCBI
38	Tatuch Y, Christodoulou J, Feigenbaum A, et al: Heteroplasmic mtDNA mutation (T→G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. Am J Hum Genet. 50:852–858. 1992.
39	Mattiazzi M, Vijayvergiya C, Gajewski CD, et al: The mtDNA T8993G (NARP) mutation results in an impairment of oxidative phosphorylation that can be improved by antioxidants. Hum Mol Genet. 13:869–879. 2004. View Article : Google Scholar : PubMed/NCBI
40	Sgarbi G, Baracca A, Lenaz G, et al: Inefficient coupling between proton transport and ATP synthesis may be the pathogenic mechanism for NARP and Leigh syndrome resulting from the T8993G mutation in mtDNA. Biochem J. 395:493–500. 2006. View Article : Google Scholar : PubMed/NCBI
41	Tatuch Y and Robinson BH: The mitochondrial DNA mutation at 8993 associated with NARP slows the rate of ATP synthesis in isolated lymphoblast mitochondria. Biochem Biophys Res Commun. 192:124–128. 1993. View Article : Google Scholar : PubMed/NCBI
42	Shoubridge EA: Mitochondrial DNA segregation in the developing embryo. Hum Reprod. 15(Suppl 2): S229–S234. 2000. View Article : Google Scholar